Bristol’s CAR-T Strategy Comes Into Focus With Two Near-Term Filings

 
• By Mandy Jackson
3d illustration of immune system T cells attacking cancer cells (CAR T-cell therapy) - Illustration
Bristol is expanding its CAR-T cell development into new indications.

More from Clinical Trials

More from R&D